Oral Squamous Cell CarcinomaSymptoms, Doctors, Treatments, Advances & More
Oral Squamous Cell Carcinoma Overview
Learn About Oral Squamous Cell Carcinoma
MUSC Health Head & Neck Tumor Center At Rutledge Tower
Jason Newman is an Otolaryngologist practicing medicine in Charleston, South Carolina. Dr. Newman is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Adenoid Cystic Carcinoma, Laryngectomy, and Gastrostomy. Dr. Newman is currently accepting new patients.
Jefferson Otolaryngology (ENT) - Honickman Center
Adam Luginbuhl is an Otolaryngologist practicing medicine in Philadelphia, Pennsylvania. Dr. Luginbuhl is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Laryngectomy, and Gastrostomy. Dr. Luginbuhl is board certified in Otolaryngology and Otolaryngology - Head & Neck Surgery. Dr. Luginbuhl is currently accepting new patients.
Avera Medical Group ENT — Head & Neck Surgery — Plaza 1
Mark Jameson is an Otolaryngologist practicing medicine in Sioux Falls, South Dakota. Dr. Jameson is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Laryngectomy, and Gastrostomy. Dr. Jameson is board certified in American Board Of Otolaryngology – Head And Neck Surgery. Dr. Jameson is currently accepting new patients.
Summary: The purpose of this study is to determine whether cervical lymph node dissection is necessarily performed in the presence of early-stage oral squamous cell carcinoma.
Summary: This is a multicenter, open-label, randomized phase III clinical trial evaluating perioperative treatment with sintilimab combined with chemotherapy in patients with locally advanced oral squamous cell carcinoma. Despite standard treatment with surgery followed by postoperative radiotherapy or chemoradiotherapy, patients with locally advanced oral squamous cell carcinoma remain at high risk of rec...


